Stock Events
Stock Events
Features
Business
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Alnylam Pharmaceuticals (A1LN34.SA) Q2 2015 Earnings
A1LN34.SA
7
May
Confirmed
Q3 2014
Q4 2014
Q1 2015
Q2 2015
-1.96
-1.57
-1.18
-0.79
Details
Expected EPS
-1.963845
Actual EPS
-1.8732060000000001
Surprise EPS
0.09
Surprise Percent
+4.62%
Description
Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -1.8732060000000001 per share for Q2 2015.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login
Home
Timeline
Search
Watchlist